Glaukos Corporation (GKOS): Price and Financial Metrics
Glaukos Corporation (GKOS)
Today's Latest Price: $66.76 USD
Updated Nov 24 7:00pm
Add GKOS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
GKOS Stock Summary
- GKOS's price/sales ratio is 13.85; that's higher than the P/S ratio of 88.84% of US stocks.
- With a year-over-year growth in debt of 231.57%, GLAUKOS Corp's debt growth rate surpasses 93.4% of about US stocks.
- Over the past twelve months, GKOS has reported earnings growth of 744.23%, putting it ahead of 98.21% of US stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to GLAUKOS Corp are MTBC, NEWR, LC, EB, and VCYT.
- GKOS's SEC filings can be seen here. And to visit GLAUKOS Corp's official web site, go to www.glaukos.com.
GKOS Stock Price Chart Interactive Chart >
GKOS Price/Volume Stats
| Current price | $66.76 | 52-week high | $70.96 |
| Prev. close | $67.02 | 52-week low | $23.31 |
| Day low | $66.67 | Volume | 261,245 |
| Day high | $68.54 | Avg. volume | 706,550 |
| 50-day MA | $56.16 | Dividend yield | N/A |
| 200-day MA | $44.89 | Market Cap | 3.00B |
Glaukos Corporation (GKOS) Company Bio
Glaukos Corporation develops and commercializes products and procedures designed for the treatment of glaucoma. The company was founded in 1998 and is based in Laguna Hills, California.
Loading social stream, please wait...